ZHENG, R.; YAO, B.; YE, Y.; LUO, R.; WU, Z.; HU, X.; YUAN, Y.; PAN, X.; LIU, C.; HUANG, L.; LUO, Y.; YANG, D.; SHANG, N.; TIAN, Y.; JIA, J. MAL, a potential immunotherapy target, is associated with poor prognosis in cancer patients: A pan-cancer study of MAL. Cellular and Molecular Biology, [S. l.], v. 70, n. 4, p. 248–254, 2024. DOI: 10.14715/cmb/2024.70.4.39. Disponível em: http://mail.cellmolbiol.org/index.php/CMB/article/view/5451. Acesso em: 9 may. 2025.